FeaturedBiotech ETFs Stable Despite Disappointing Treatment Date From GileadBy Ian YoungApril 23, 2020
Disruptive Technology Channel2 Biotechnology ETFs That Could Be Good For DiversificationBy Ian YoungMarch 26, 2020
Disruptive Technology ChannelA Biotech ETF at the Center of a Profit/Peril MarketBy Tom LydonFebruary 27, 2020
Thematic Investing ChannelSmaller Companies, Big Returns For This Biotech ETFBy Tom LydonFebruary 21, 2020
Thematic Investing ChannelBiotech ETFs Jump: Keep an Eye on XBI, IBB & SBIOBy Frank HolmanJune 18, 2019
Contributed4 Benefits of Equal-Weighted ETFsBy David Mazza -- State Street Global AdvisorsNovember 9, 2015
